Scott-Whitmore Chair in Hematology & Thromboembolism
University Health Network
Role Managed by:
Head of Research
Primary Practice Group: Health and Social Care
Salary & Benefits: Competitive
Closing Date: 29/09/2017
The Princess Margaret Cancer Centre is part of the University Health Network (UHN) and works together with Toronto General Hospital, Toronto Western Hospital, Princess Margaret Cancer Centre, and the Toronto Rehabilitation Institute as part of the larger research mission at UHN. We are the largest comprehensive cancer centre in Canada and considered one of the top 5 in the world. The Division of Medical Oncology and Hematology is the largest comprehensive program of its kind in Canada and dedicated to providing some of the most advanced and novel approaches to medical and hematologic oncology worldwide. The Blood Disorders Program is a core program within the Division and is dedicated to managing diseases of the blood and bone marrow. The Program comprises the Thrombosis & Hemostasis Clinic, Red Blood Cell Clinic, and General Hematology Clinic.
We are seeking an outstanding research leader who brings a strong record of scholarly accomplishments in thrombosis especially as it relates to arterial and cardiac disease, and to cancer. The successful candidate’s expertise may lie anywhere along the spectrum of early clinical investigation and/or therapeutics and patient outcomes, but the ability to integrate these domains and lead a collaborative translational research program in the aforementioned priority areas is critical. They will bring experience in fostering innovative and collaborative multi-disciplinary, multi-departmental and international educational and research initiatives and excellence.
This Chair was established through a bequest from the estate of Mr. David G. Whitmore to honour Dr. J. Gerald Scott, former Head, Division of Hematology and Oncology at The Toronto Hospital and Associate Professor of Medicine at the University of Toronto. The aim of Mr Whitmore’s generous gift of $2,000,000 is to facilitate basic and clinical research in Haematology and Gene Therapy Research.
This position includes a primary academic appointment in the Division of Hematology, Department of Medicine at the University of Toronto. They will also join the Toronto General Hospital’s Thrombosis and Hemostasis program and work in close collaboration with clinical colleagues in the Princess Margaret Cancer Centre and Peter Munk Cardiac Centre.
The successful candidate must hold an MD degree, be eligible for a full-time clinical academic appointment at the rank of Associate or Full Professor at the University of Toronto and for certification with the Royal College of Physicians and Surgeons of Canada in Hematology, and have, or be eligible for licensure in Ontario. Should the successful candidate require significant basic and/or clinical-science research facilities, an appointment in the Toronto General Hospital Research Institute will be provided.
UHN is partnering with the executive search firm Perrett Laver on this search process. Further information, including details of how to apply, can be downloaded at http://www.perrettlaver.com/candidates quoting reference 3151. For informal inquiries, please contact Audrey Gamet at Audrey.Gamet@perrettlaver.com or + 1 312 380 0797.
The deadline for application is noon on Friday 29th September, 2017